CNR2 and Miyoshi myopathy: In MM, it was already studied the effect of CBD, THC, the synthetic cannabinoid agonists WIN‐55, PGN‐6, ‐17, ‐34, and ‐72, the inverse agonist of CB2 phenylacetylamide (PAM), and β‐caryophyllene, which showed promising anticancer effects in vitro and, WIN‐55, in vivo in animal models.19